Literature DB >> 3234470

Effect of lithium treatment on the GH-clonidine test in affective disorders.

F Brambilla1, M Catalano, A Lucca, E Smeraldi.   

Abstract

The effects of short-term lithium (Li) administration on alpha 2-adrenoceptor sensitivity was studied in 10 healthy volunteers and in 15 patients with normothymic, phasic depressive disorders. The GH-clonidine test was used to examine alpha 2-adrenoceptor sensitivity, administered before and after Li treatment (600 mg/day for 7 days in controls and for 15 days in patients). Before treatment, the GH response to clonidine in the patients was blunted, and afterwards it tended to increase in the patients and it was significantly decreased in the controls. The difference between the response in the two groups was significant and was correlated both with the diagnosis and the pretreatment GH response to the stimulus. The opposing pattern of the response in patients and controls to Li administration suggests that the drug exerts a modulatory effect on alpha 2-adrenoceptor sensitivity, with up or down regulation inversely correlated with pretreatment status.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3234470     DOI: 10.1007/bf00637595

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Lithium effects on adrenergic receptor supersensitivity in rat brain.

Authors:  S Treiser; K J Kellar
Journal:  Eur J Pharmacol       Date:  1979-09-01       Impact factor: 4.432

2.  The effect of imipramine and lithium on alpha- and beta-receptor binding in rat brain.

Authors:  J E Rosenblatt; C B Pert; J F Tallman; A Pert; W E Bunney
Journal:  Brain Res       Date:  1979-01-05       Impact factor: 3.252

3.  Endocrine changes in psychiatric diseases.

Authors:  P H Gruen
Journal:  Med Clin North Am       Date:  1978-03       Impact factor: 5.456

4.  Evaluation of alpha-adrenergic responsiveness to clonidine challenge and noradrenergic metabolism in the affective disorders and their treatment.

Authors:  L J Siever; T W Uhde; E K Silberman; C R Lake; D C Jimerson; S C Risch; N H Kalin; D L Murphy
Journal:  Psychopharmacol Bull       Date:  1982-10

5.  Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports.

Authors:  L J Siever; D Pickar; C R Lake; R M Cohen; T W Uhde; D L Murphy
Journal:  J Clin Psychopharmacol       Date:  1983-02       Impact factor: 3.153

6.  Effect of lithium on circadian neurotransmitter receptor rhythms.

Authors:  M S Kafka; A Wirz-Justice; D Naber; P J Marangos; T L O'Donohue; T A Wehr
Journal:  Neuropsychobiology       Date:  1982       Impact factor: 2.328

7.  Effect of clonidine on growth hormone release in psychiatric patients and controls.

Authors:  N Matussek; M Ackenheil; H Hippius; F Müller; H T Schröder; H Schultes; B Wasilewski
Journal:  Psychiatry Res       Date:  1980-03       Impact factor: 3.222

8.  Growth hormone and other responses to clonidine in patients with endogenous depression.

Authors:  S A Checkley; A P Slade; E Shur
Journal:  Br J Psychiatry       Date:  1981-01       Impact factor: 9.319

9.  Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

Authors:  D S Charney; G R Heninger; D E Sternberg; K M Hafstad; S Giddings; D H Landis
Journal:  Arch Gen Psychiatry       Date:  1982-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.